Pinpointing barriers to timely head and neck cancer treatment in rural areas

A new study led by researchers at Dartmouth Cancer Center pinpoints why many patients in rural areas experience delays in ...

Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026

Mouse analog of MICVO (maMICVO) monotherapy produced dose-dependent inhibition of tumor growth in a syngeneic preclinical model of HNSCCmaMICVO ...
Dermatology Advisor

Early-Onset Oral Cavity Squamous Cell Carcinoma Increasingly Presenting as Tongue Tumors

The incidence of early-onset oral cavity squamous cell carcinoma on the tongue, the most common subsite, increased over time.

I Was Left in Agony After a Skin Treatment—Now I’m Warning Younger People

Belinda Shipman told Newsweek that the monthlong treatment felt like her "face, body and mind were literally being torn apart ...
Cancer Therapy Advisor

6 Factors Patients May Not Know Increases CSCC Risk

What factors may put patients at an increased risk of cutaneous squamous cell carcinoma, and what should they know about ...
Thorax

Sex-based differences in effectiveness of immune checkpoint inhibitors in the treatment of advanced non-small-cell lung cancer: systematic review and meta-anal…

Background Sex-based differences in immune response are well established, but whether men and women derive comparable benefit ...

Cancer's hidden switch may sit in the cell membrane, forcing growth receptors into permanent overdrive

Cells are enveloped by a lipid membrane that gives them structure and provides a barrier between the cell and its environment ...

Biological shield can prevent skin cancer cells from transforming into aggressive metastatic forms

A new study has identified a molecular guardian that keeps skin cells from forgetting what they are and transforming into ...

Lung Cancer Research Foundation Grants Team Science Award Focused on Curing EGFR-Mutant Lung Cancers

The Lung Cancer Research Foundation (LCRF) announces the first recipients of its LCRF Team Science Award on Advancing Therapies Toward Curing EGFR Mutated Lung Cancers. The project, "A novel ...

What is ‘Saree cancer’? Why this rare condition develops and the simple habits that can help prevent it

For millions of women across India, the saree is more than attire. It carries tradition, identity, and comfort. But, tucked ...
PharmiWeb

Ifinatamab Deruxtecan Granted Priority Review in the U.S. for Adult Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer who Experienced Disease Progression ...

Lung01 Phase 2 trial, with support from IDeate-PanTumor01 Phase 1/2 trialIf approved, ifinatamab deruxtecan would be a first-in-class B7-H3 directed DXd antibody drug conjugate for these patients ...

Transgene Completes Patient Randomization in Phase 2 Part of Clinical Trial Evaluating TG4050 in the Adjuvant Treatment of Head and Neck Cancer

Two-year disease-free survival from evaluable Phase 2 patients expected by the end of Q1 2028.Strasbourg, France, April 13, 2026, 8:00 a.m. CET – ...